Monte Carlo method for predicting of cardiac toxicity: hERG blocker compounds.
暂无分享,去创建一个
[1] Andrey A Toropov,et al. Quasi-SMILES and nano-QFAR: united model for mutagenicity of fullerene and MWCNT under different conditions. , 2015, Chemosphere.
[2] Bruno O Villoutreix,et al. Computational investigations of hERG channel blockers: New insights and current predictive models. , 2015, Advanced drug delivery reviews.
[3] Andrey A Toropov,et al. Quasi-QSAR for mutagenic potential of multi-walled carbon-nanotubes. , 2015, Chemosphere.
[4] Jerzy Leszczynski,et al. QSAR model as a random event: A case of rat toxicity. , 2015, Bioorganic & medicinal chemistry.
[5] Michael Houghton,et al. A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity. , 2014, Toxicology letters.
[6] Andrey A Toropov,et al. Optimal descriptor as a translator of eclectic data into endpoint prediction: mutagenicity of fullerene as a mathematical function of conditions. , 2014, Chemosphere.
[7] Andrey A Toropov,et al. Optimal descriptor as a translator of eclectic information into the prediction of membrane damage by means of various TiO(2) nanoparticles. , 2013, Chemosphere.
[8] Jerzy Leszczynski,et al. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells. , 2013, Chemosphere.
[9] Cheol‐Hee Kim,et al. Predicted drug-induced bradycardia related cardio toxicity using a zebrafish in vivo model is highly correlated with results from in vitro tests. , 2013, Toxicology letters.
[10] Jerzy Leszczynski,et al. CORAL: QSPR model of water solubility based on local and global SMILES attributes. , 2013, Chemosphere.
[11] Jerzy Leszczynski,et al. Novel application of the CORAL software to model cytotoxicity of metal oxide nanoparticles to bacteria Escherichia coli. , 2012, Chemosphere.
[12] Yadong Chen,et al. Predicting the potency of hERG K+ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models , 2012, Journal of Molecular Modeling.
[13] Lu Chen,et al. A Critical Assessment of Combined Ligand- and Structure-Based Approaches to hERG Channel Blocker Modeling , 2011, J. Chem. Inf. Model..
[14] Srikanta Sen,et al. Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. , 2011, European journal of medicinal chemistry.
[15] Ferran Sanz,et al. A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity , 2011, J. Chem. Inf. Model..
[16] M. Sanguinetti,et al. SYMPOSIUM REVIEW: Revealing the structural basis of action of hERG potassium channel activators and blockers , 2010, The Journal of physiology.
[17] E. Matthews,et al. Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities. , 2010, Regulatory toxicology and pharmacology : RTP.
[18] Gábor Csányi,et al. Gaussian Processes: A Method for Automatic QSAR Modeling of ADME Properties , 2007, J. Chem. Inf. Model..
[19] Dimitris K Agrafiotis,et al. A QSAR Model of hERG Binding Using a Large, Diverse, and Internally Consistent Training Set , 2006, Chemical biology & drug design.
[20] Gabriele Cruciani,et al. Predictive models for hERG potassium channel blockers. , 2005, Bioorganic & medicinal chemistry letters.
[21] David Weininger,et al. SMILES, 3. DEPICT. Graphical depiction of chemical structures , 1990, J. Chem. Inf. Comput. Sci..
[22] David Weininger,et al. SMILES. 2. Algorithm for generation of unique SMILES notation , 1989, J. Chem. Inf. Comput. Sci..
[23] David Weininger,et al. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..